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Abstract  
Introduction: Few studies have established the role of maternal HIV infection on neonatal disease and death. In order to determine whether 
neonatal morbidity and mortality were associated to maternal HIV infection, a case-control study was conducted in the neonatal unit of the 
University Teaching Hospital of Yaoundé from July 2006 to December 2007. Methods: Babies born from HIV positive mothers were recruited as 
cases. For each case, two babies born from HIV negative mothers were selected as controls. Informed verbal consent was obtained from the 
mother before inclusion of the newborn in the study. Information on demographics, history of pregnancy, diseases and outcome of the newborns 
were extracted from patients’ files. The distribution of these parameters between cases and control was analyzed using chi-square. Association of 
demographics,  clinical  and  paraclinical  parameters  with  mortality  was  explored  using  univariate  analysis  and  logistic  regression.  Data  were 
analyzed using Epi Info version 3.5.1 Windows. Results: Out of 240 newborns enrolled, 80 were cases and were 160 controls. The mean age of 
cases was 1.69±2.73 days compared to 1.46±2.36 days for controls (p=0.26). Cases significantly differed from controls on mother’s marital status 
(p=0.02),  level  of  education  (p<0.001),  number  of  prenatal  consultations  (p<0.001),  anemia  chemoprophylaxis  (p=0.01)  and  drug  abuse 
(p<0.001). Cases and controls were similar for prematurity, respiratory distress, sepsis, meningitis and urinary tract infection. The death rate was 
identical in both groups (p=0.52). Using Univariate analysis, risk factors associated to mortality in both groups were prematurity (p<0.001) and 
low birth weight (p<0.001). Conclusion: This study showed no statistical difference in morbidity and mortality between newborns from HIV 
positive and HIV negative mothers.  
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Introduction 
 
In Africa, HIV infection rates among pregnant women ranged from 15 to 40 percent in countries with the highest overall HIV prevalence in 2006 
[1]. Even though HIV is not a direct cause of neonatal death, maternal HIV status affects newborn survival by causing an increased risk of stillbirth 
and death in the neonatal period and infancy; this increase risk extend to those babies who do not become HIV positive [2]. The interaction of HIV 
with other infections and the indirect effects of HIV, such as poverty and maternal illness, contribute to the poor outcome of these newborns. It 
has been established that newborns exposed to mother’s HIV infection have a higher mortality rate than those not exposed [3-5]. HIV is more 
prevalent in Cameroon, and the pattern of HIV epidemic is changing overtime with a prevalence in the general population that went from 5.5 in 
2001 to 5.3 in 2009 [2]. Women attending antenatal visits are more aware of being tested for HIV infection. The rate of HIV testing acceptance 
during pregnancy went from 31% in 2005, 77.7% in 2007 to 83.4% in 2009 [6]. To answer the question whether maternal HIV infection is 
associated to newborn’s morbidity and mortality in our setting, we performed a hospital based study, with the aim of addressing the issue of 





This was a case control study carried out at the neonatology Unit of the University Teaching Hospital of Yaoundé (UTHY) from July 2006 to 
December  2007.  The  UTHY  is  a  referral  hospital  that  had  a  5  bedded  labor  room.  The  staff  of  the  maternity  comprises  7  gynecologists 
/obstetricians, 9 residents and 18 nurses including 2 midwives. Cases included in the study were newborns from mothers with known HIV positive 
serology, born in the maternity of the UTHY and admitted in the neonatal unit of the same hospital. Newborns from HIV negative mothers, born in 
the same hospital and admitted in the same neonatal unit were taken as controls. Newborns with life threatening congenital anomalies were 
excluded from the study because of the potential interaction with morbidity and mortality.  
  
Since 2005, the hospital policy to prevent mother-to-child transmission of HIV is to admit in the neonatal unit all baby from HIV positive mothers, 
free of charges, for up to 72 hours. The aim of this policy is to insure that mothers understand the administration of antiretroviral drugs and the 
feeding  option  of  the  newborn  while  assuring  psychosocial  support  to  the  parents.  The  package  for  HIV  positive  pregnant  women  included 
antiretroviral (ARV) drugs such as the combined tablets of Zidovudine and Lamivudine at 300/150 mg every 12 hours starting at 28 weeks of 
pregnancy and a tablet of Nevirapine 200 mg at onset of labor. Newborns receive Zidovudine 4 mg/kg/day every 12 hours for 4 weeks and a single 
dose of Nevirapine 2 mg/kg within 72 hours of delivery.  
  
Informed verbal consent was obtained from mothers before enrolment in the study. Ethical clearance was obtained from the National Ethical 
Committee.  
  
The selection of cases was as followed: babies born from an HIV positive mother were randomly selected from the neonatology patient register. In 
order to increase the power of the study, for each case, two babies born from HIV negative mothers were selected as controls. This was done until 
fulfillment of the calculated sample size, taking into account a proportion of 15% of HIV infected newborns.  
  
Information was extracted from mothers’ files regarding history of pregnancy and delivery and other relevant demographics. Information collected 
from the newborn files included age and sex of the baby, anthropometric parameters, glycemia, calcemia, infection and other clinical problems 
presented during the length of stay in hospital. Neonatal sepsis, meningitis and urinary tract infection were validated when bacteria were isolated 
respectively in the culture of blood, central nervous system fluid and urine. Data were analyzed using Epi Info version 3.5.1 Windows. No matching 
criterion was used in the analysis. The Chi square test was performed to compare proportions and the level of significance was set at 0.05. 
Variables significantly associated with mortality at a level of p<0.07 on the univariate analysis and those variables that we thought could be 
associated with mortality in a fishing expedition were further put in a logistic regression model to identify independent risk factors. The assumption 





A total of 240 newborns were enrolled in the study. A male newborn with spina bifida and a female with omphalocele were excluded from the 
study. Out of the 80 newborns from HIV-positive mothers, 42 (52.5%) were males and 38 (47.5%) females. In the group of newborns from HIV-
negative mothers, 85 (53.1%) were males and 75 (46.9%) females (p=0.07). The age range of the study population varied from birth to 13 days. 
The more represented age range was from 2 to 4 days, 28 (35%) cases compared to 77 (48.1%) controls. The mean age in the case group was 
2.13±3.34 days compared to 1.46±2.36 days for controls (p=0.26).  
  
Table  1  shows  the  demographic  features  and  antenatal  characteristics  of  HIV-positive  and  HIV-negative  mothers.  HIV  positive  mothers,  46 
(57.5%) were more likely to attend UTHY ANC than HIV negative mothers (n=70, 43.8%, p=0.03). The mean maternal ages between HIV positive 
and HIV negative mothers was comparable, 27.97±4.86 years in cases and 26.99±5.34 years in controls (p=0.10). Most of the mothers in the 
case group were single 47 (58.8%) and multiparous 60 (75%) while in the control group most of them were respectively married 89 (56.6%) 
(p=0.02) and 101 (63.1%) were multiparous (p=0.39). As far as education was concerned, the majority of mothers of the study population was at 
college level, 48 (60%) for cases and 118 (73.8%) for controls (p<0.001). Drug abuse was reported by 6 mothers in the HIV positive group 
compared to 1 mother in the HIV negative group (p<0.001). Alcohol was reported by 4 and heavy tobacco smoking by 2 HIV positive mothers; 
one HIV negative mother reported alcohol consumption. Malaria chemoprophylaxis during pregnancy was noted in 71 cases (88.8%) compared to 
148 controls (93.1%) (p<0.18) but for anemia chemoprophylaxis 73 (91.2%) of HIV positive mothers received ion and folate tablets against 157 
(98.1%) in the group of HIV negative mothers (p=0.01). Malaria in pregnancy was observed in 19 (23.8 %) cases and 17 (10.6%) controls 
(p<0.001). HIV-positive women who received antiretroviral therapy on the basis of their lymphocytes count were 74 (92.5%) in number and 11 Page number not for citation purposes  3 
(14.8%) were put on tritherapy throughout pregnancy; 36 (48.6%) were on Zidovudine during pregnancy plus Nevirapine at onset of labor while 
17 (22.9%) had Combivir without Nevirapine at onset of labor and 10 (13.5%) had Nevirapine alone at onset of labor.  
  
HIV testing was done and obtained at labor for 6 HIV positive mothers. These women did not receive ARV but their offspring had Nevirapine and 
Zidovudine as the other newborns. Looking at t history of delivery, premature rupture of membranes was noticed in 25 cases (31.3%) compared to 
75 (46.9%) controls (p=0.01). Most of the newborns were delivered vaginally, 63 (78.8%) in HIV exposed babies and 115 (71.9%) in newborns 
from HIV negative mothers. The difference was not statistically significant (p=0.13). Premature deliveries were 22 (27.5%) in cases compared to 
34 (21.9%) in controls (p=0.41). The mean weight in HIV exposed newborns was 2950±579g while it was 2969±748g for controls (p=0.9). The 
mean height was 48.43±2.66 cm for cases compared to 48.92±3.76 cm for controls (= 0.14).  
  
Table 2 illustrates morbidity and mortality profile of the newborns from HIV positive and HIV negative mothers. The number of newborns in the 
case group with an Apgar score below 6 at 5 minutes was 14 (17%) compared to 53 (33.1%) in the control group p<0.001). There was no 
statistically significant difference between the newborns from HIV positive mothers and those from HIV negative mothers as concerns low birth 
weight (p=0.53), body temperature (p= 0.30), metabolic disorders such as hypoglycemia (p=039) and hypocalcemia (p=0.77) and neonatal 
infection, septicemia (p=053), meningitis (p=0.44), urinary tract infection (p=031). Among the cases, 14 (17.5%) were on breastfeeding while 154 
(96.3%) controls were on the same choice of feeding (p<0.001). The length of stay in hospital was comparable in both groups 9.1± 8.3 days for 
cases against 8.8± 8.6 days for controls (p=0.57).  
  
The number of death in cases was 8 (10%) compared to 15 (9.4%) in controls and the difference between the two groups was not statistically 
significant (p=0.52). The univariate analysis for mortality in table 3 shows that factors associated with mortality were prematurity (OR =3.6; 95% 
CI =1.47-8.87; p=0.006) and low birth weight (OR=3.31; 95% CI = 1.3-8.09; p=0.009). None of the covariates studied was associated with 





The study sample represented (8.3%) of the 956 HIV exposed and (7.6%) of the 2103 non-HIV exposed newborns delivered in the UTH maternity 
from July 2006 to December 2007. In this study, HIV positive mothers had a low level of education and were more likely to be single compared to 
HIV negative mothers as shown in Zambia and Rwanda [7,9,10]. The two groups of mothers were comparable as regards to age and income 
generating activities as shown in a previous study in Cameroon [11].  
  
Prenatal and delivery history  
  
The majority of HIV positive and HIV negative mothers fulfilled the World Health Organization requirements of at least 4 ANC during pregnancy 
[12,13]. The number of antenatal consultations was similar in both groups of mothers; though a higher proportion of HIV positive mothers had on 
average 4 ANC visits more than HIV negative mothers. In addition, HIV positive mothers were more likely to come to ANC visits at the UTHY 
probably because of their related medical problems, as observed with the higher proportion of malaria in pregnancy. This disease was highly 
noticed in a study in Malawi [14] where the prevalence of malaria in HIV positive mothers reached (56.3%) compared to (36.5%) for HIV negative 
mothers. The discrepancy could be explained by the fact that our study population was urban in majority; in addition, a high proportion of women 
received malaria prophylaxis (88.8% of HIV positive mothers and 92.5 % of the HIV negative mothers). Iron deficiency anemia is the most 
common cause of anemia in pregnancy. The rate of malaria prophylaxis in this study was considerable and the majority of women had the required 
number of ANC visits; we can therefore presume that these women received nutritional counseling, iron and folic acid for anemia prophylaxis. 
Theses interventions are important in reducing anemia in pregnancy [13] and might explain why we did not find a single case of anemia in our 
study.  
  
Neonates morbidity and mortality  
  
The majority of newborns were males in the two groups but the difference was not statistically significant as pointed out by some authors [15,16]. 
The prevalence of prematurity was high in the two groups and the difference was not statistically significant. This was in accordance with the 
findings of Lepage et al [7]. Temmerman et al noticed a significant difference, 21.1% in the group of HIV infected mothers compared to 9.4% in 
HIV negative mothers [2] but, in this study, mothers were recruited as cases on the basis of having a low birth weight that could bias the result 
towards prematurity. Further, Haeri et al found that prematurity was more common among HIV-positive women than uninfected women (OR 
=2.27, 95% CI= 1.22-4.25) [17] but mothers were more likely to have heavy tobacco smoking and cocaine use. Neonatal asphyxia was high 
among cases compared to controls. This finding could be explained by the fact that the controls were newborns hospitalized in the neonatal unit 
because of birth trauma as this was a major reason for admission. The number of low birth weights was not statistically different between 
neonates born from HIV positive and HIV negative mothers. This finding does not concord with Ezeaka et al in Nigeria [18] who found that there 
were three times more low birth weights in the HIV positive mothers than in the HIV uninfected mothers (OR=3.47; 95 CI=1.69-7.27; P= 0.0003). 
The mean weight of newborns was similar in both groups. This was contrary to other studies which found that newborns exposed to HIV were 
more likely to have low birth weights [2,7]. Considering the adequate numbers of antenatal care we could assume that infected women were well 
managed during pregnancy, and the fact that they took antiretroviral therapy early enough, before the third trimester of pregnancy, could explain 
why  the  difference  of  mean  weight  was  not  statistically  significant.  These  findings  are  similar  to  those  of  other  authors  who  showed  that 
anthropometric measurements of infants born from asymptomatic HIV infected mothers are comparable to those in the general population in 
contrast to children of drug-addicted mothers [19] in our study, there was only one HIV negative mother that was drug-addicted. Neonatal 
mortality was similar in the two groups, as found in other studies in Rwanda, Malawi, Zambia and Tanzania [7,8] . Neonatal death rates were 94 
per 1000 in HIV exposed babies compared to 100 per 1000 on controls. These figures were high compared to the 40 per 1000 reported at national Page number not for citation purposes  4 
level [20]. The explanation could reside on the fact that this is a referral hospital and many of the deliveries were conducted in women who were 
not managed during pregnancy in this hospital and who came late, the high level of birth asphyxia found being part of this delay.  
  
Factors associated with mortality in the univariate analysis were prematurity and low birth weight even though these and other variables analyzed 
did not appear as risk factors for mortality in a logistic regression model. However, some authors have shown that prematurity and low birth 
weight were considerably associated to morbidity and mortality in the neonatal period as well as in the first year of life [21-23] and that there was 
a direct correlation between vertical transmission of HIV, low birth weight and high mortality [23-26].  
  
This study has a limitation that it could not tell strongly the number of mothers on ARV therapy that was symptomatic and their biological profiles. 
So there is a need to address this issue in further studies as misclassification bias might lead to the failure to pick up a difference, if any, between 
the two groups of neonates as far as prematurity, low birth weight and mean birth weight are concerned. Taking into consideration the variables 
that showed a trend to significance, the sample size was small enough to pick up differences between newborns from HIV positive and HIV 
negative mothers. A bias could have been introduced because of the choice of controls as they were more likely to have neonatal asphyxia that 
was the primary reason for admission in the neonatal unit. This was a hospital based study which did not cover the overall neonatal period; 





This case control study showed that mortality rate was similar in newborns from HIV positive mothers and HIV negative mothers. Prematurity and 
low birth weight were potential risk factors for mortality in the univariate analysis but failed to be demonstrative in a logistic regression model. The 
impact of maternal HIV infection might not be evident in the neonatal period. Further studies are in progress and will take into account HIV 
positive mothers’ clinical and biological stages. However, health professionals should be aware of and properly address the issue of prematurity 
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Table  1:  Sociodemographic  and  Antenatal  characteristics  of  HIV-  positive  and  HIV-negative  mothers  of  the  newborns, 
University Teaching Hospital, July 2006-December 2007 
Variable   HIV+ mothers 
n=80 
  HIV- mothers 
n=160 
P value 
Demographics         
Mean age of the mothers (years)  27.32 ± 5.20    26.99 ± 5.34  0.10 
Married mothers (n %)  33 (41.3)    89 (55.6)  0.02 
College level of education (n %)  48 (60)    118 (73.8)  <0.001 
Income activity generating (n %)  40 (50)    63 (39.4)  0.07 
         
History of pregnancy and delivery         
Multiparity (n %)  64 (80)    120 (75)  0.39 
Drug abuse (n %)  6 (7.5)    1 (0.6)  <0.001 
UTHY site of ANC  46 (57.5)    70 (43.8)  0.03 
At least 4 ANC (n %)   70 (87.5)    117 (73.1)  <0.001 
Malaria in pregnancy (n %)  19 (23.8)    17 (10.6)  <0.001 
Anemia in pregnancy (n %)  0    0   
Syphilis (n %)  1 (1.3)    3 (1.9)  0.58 
Malaria chemoprophylaxis (n %)  71 (88.8)    148 (92.5)  0.18 
Anemia chemoprophylaxis (n %)  73 (91.3)    157 (98.1)  0.01 
Gestational age ≤ 37 weeks (n %)  22 (27.5)    35 (21.9)  0.41 
Normal delivery (n %)  63 (78.8)    115 (71.9  0.13 
Premature rupture of membranes (n %)  25 (31.3)    75 (46.9)  0.01 
Choice of breastfeeding  14 (17.5)    154 (96.3)  <0.001 
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Table 2: Morbidity and mortality profile of the neonates born from HIV- positive mothers and HIV-negative mothers, University 
Teaching Hospital, July 2006-December 2007 







HIV- mothers  
n=160 
P value 
Neonatal asphyxia (n %)  14 (17.5)    53 (33.1)  <0.001 
Low birth weight (n %)  16 (20)    35 (21.8)  0.53 
Mean birth weight  (g)  2950±578    2969±748  0.90 
Mean height (cm)  48.43±2.66    48.92±3.76  0.14 
Hypothermia (n %)               23 (28.8)    61 (38.1)  0.30 
Hypoglycemia (n %)  10 (12.5))    17 (10.6)  0.39 
Hypocalcaemia (n %)  9 (11.3)    20 (12.5)  0.77 
Neonatal sepsis (n %)  9 (11.3)    19 (11.9)  0.53 
Neonatal meningitis (n %)  4 (5.0)    6 (3.8)  0.44 
Neonatal respiratory distress (n %)  12 (15)    20 (12.5)  0.36 
Urinary tract infection (n %)  3 (3.8)    3 (1.9)  0.31 
Neonatal jaundice (n %)  21 (26.3)    42 (26.3)  0.55 
Mean length of stay in hospital (days)  9.1 ± 8.3    8.8 ± 8.6  0.57 
Neonatal death (n %)  8 (10)    15 (9.4)  0.52 
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Table 3: Univariate analysis and logistic regression of risk factors for mortality in neonates born from HIV-positive and HIV-negative 
mothers, University Teaching Hospital, July 2006-December 2007 







OR  CI (95%)  P value 
 
Univariate analysis 
Income generating activity  4 (10)  6 (9.5)  1.02  0.43-2.44  0.48 
Malaria in pregnancy  1 (5.3)  1 (5.9)  0.51  0.11-2.28  0.28 
At least 4 ANC   7 (10)  10 (8.5)  1.30  0.47-3.56  0.38 
Malaria chemoprophylaxis  8 (11.3)  12 (8.1)  0.58  0.16-2.12  0.30 
Premature rupture of membranes  2 (8.0)  7 (9.3)  0.89  0.36-2.19  0.49 
Prematurity  4 (25)  6 (18.8)  3.6  1.47-8.87  0.006 
Low birth weight < 2500g  3 (18.8)  7 (20)  3.31  1.3-8.09  0.009 
Neonatal sepsis  0 (0)  2 (10.5)  0.70  0.15-3.15  0.48 
Neonatal meningitis  1 (25)  0 (0)  1.04  0.12-8.6  0.64 
Neonatal respiratory distress  4 (33.3)  6 (30)  2.76  0.51-14.82  0.20 
Anemia  0 (0)  2 (40)  2.38  0.4-11.70  0.25 
     
Multivariate analysis       
Prematurity  -  -  5.69  (0.74-43.54)  0.09 
Low birth weight  -  -  2.54  (0.33-19.34)  0.36 
Malaria chemoprophylaxis  -  -  3.92  (0.77-19.79)  0.09 
Premature rupture of membranes  -  -  0.88  (0.25-3.06)  0.84 
Malaria in pregnancy  -  -  0.65  (0.07-5.66)  0.70 
At least 4 ANC  -  -  1.06  (0.30-3.75)  0.91 
  
  
 